Viking Therapeutics Stock Filter Stocks by Fundamentals
VKTX Stock | USD 51.99 0.60 1.14% |
Viking Therapeutics fundamentals help investors to digest information that contributes to Viking Therapeutics' financial success or failures. It also enables traders to predict the movement of Viking Stock. The fundamental analysis module provides a way to measure Viking Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Viking Therapeutics stock.
Viking | Cash and Equivalents |
Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
All Next | Launch Module |
Viking Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Viking Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Viking Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
Viking Fundamentals
Return On Equity | -0.15 | ||||
Return On Asset | -0.13 | ||||
Current Valuation | 4.93 B | ||||
Shares Outstanding | 111.44 M | ||||
Shares Owned By Insiders | 5.96 % | ||||
Shares Owned By Institutions | 75.48 % | ||||
Number Of Shares Shorted | 13.28 M | ||||
Price To Earning | (3.17) X | ||||
Price To Book | 6.43 X | ||||
EBITDA | (100.83 M) | ||||
Net Income | (85.89 M) | ||||
Cash And Equivalents | 155.02 M | ||||
Cash Per Share | 2.02 X | ||||
Total Debt | 1.26 M | ||||
Debt To Equity | 0.01 % | ||||
Current Ratio | 11.74 X | ||||
Book Value Per Share | 8.18 X | ||||
Cash Flow From Operations | (73.38 M) | ||||
Short Ratio | 3.89 X | ||||
Earnings Per Share | (0.94) X | ||||
Price To Earnings To Growth | (0.03) X | ||||
Target Price | 112.57 | ||||
Number Of Employees | 30 | ||||
Beta | 0.99 | ||||
Market Capitalization | 5.86 B | ||||
Total Asset | 368.49 M | ||||
Retained Earnings | (377.94 M) | ||||
Working Capital | 348.09 M | ||||
Current Asset | 15.2 M | ||||
Current Liabilities | 1.98 M | ||||
Net Asset | 368.49 M |
About Viking Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Viking Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Viking Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Viking Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Viking Stock Analysis
When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.